Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Finn

Showing results (321-330 of 527) with videos related to

Pageof 53
Sort By:
Developmental Science|July 20, 2016
Functional brain organization of working memory in adolescents varies in relation to family income and academic achievementAmy S Finn, Jennifer E Minas, Julia A Leonard, et al.
Journal of the American College of Surgeons|February 19, 2015
A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipientsVatche G Agopian, Michael Harlander-Locke, Ali Zarrinpar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumorsMichael S Bobola, Laura S Finn, Richard G Ellenbogen, et al.
Hepatology (Baltimore, Md.)|January 29, 2017
AASLD guidelines for the treatment of hepatocellular carcinomaJulie K Heimbach, Laura M Kulik, Richard S Finn, et al.
ESMO Open|March 19, 2025
Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trialN Harbeck, V Dieras, K A Gelmon, et al.
Liver Cancer|October 22, 2024
Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECTRichard S Finn, Shukui Qin, Fabio Piscaglia, et al.
Cardiovascular and Interventional Radiology|February 4, 2022
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative TreatmentJosep M Llovet, Arndt Vogel, David C Madoff, et al.
Liver Cancer|September 28, 2023
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III StudyMasatoshi Kudo, Richard S Finn, Peter R Galle, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2020
Functional connectivity predicts changes in attention observed across minutes, days, and monthsMonica D Rosenberg, Dustin Scheinost, Abigail S Greene, et al.
Liver Cancer|August 20, 2025
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus BevacizumabJaekyung Cheon, Baek-Yeol Ryoo, Hong Jae Chon, et al.
Pageof 53

Showing results (321-330 of 527) with videos related to

Sort By:
Pageof 53
Developmental Science|July 20, 2016
Functional brain organization of working memory in adolescents varies in relation to family income and academic achievementAmy S Finn, Jennifer E Minas, Julia A Leonard, et al.
Journal of the American College of Surgeons|February 19, 2015
A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipientsVatche G Agopian, Michael Harlander-Locke, Ali Zarrinpar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumorsMichael S Bobola, Laura S Finn, Richard G Ellenbogen, et al.
Hepatology (Baltimore, Md.)|January 29, 2017
AASLD guidelines for the treatment of hepatocellular carcinomaJulie K Heimbach, Laura M Kulik, Richard S Finn, et al.
ESMO Open|March 19, 2025
Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trialN Harbeck, V Dieras, K A Gelmon, et al.
Liver Cancer|October 22, 2024
Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECTRichard S Finn, Shukui Qin, Fabio Piscaglia, et al.
Cardiovascular and Interventional Radiology|February 4, 2022
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative TreatmentJosep M Llovet, Arndt Vogel, David C Madoff, et al.
Liver Cancer|September 28, 2023
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III StudyMasatoshi Kudo, Richard S Finn, Peter R Galle, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2020
Functional connectivity predicts changes in attention observed across minutes, days, and monthsMonica D Rosenberg, Dustin Scheinost, Abigail S Greene, et al.
Liver Cancer|August 20, 2025
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus BevacizumabJaekyung Cheon, Baek-Yeol Ryoo, Hong Jae Chon, et al.
Pageof 53